Effect of Oral Supplementation With Curcumin on Insulin Sensitivity in Subjects With Prediabetes

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 142 participants.

Also called NCT03917784

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 142 participants (planned count) (from the registry)
Sponsor
Hospital General de México Dr. Eduardo Liceaga (from the registry)
Registry
  • NCT NCT03917784
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Mexico (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT03917784. Randomized; triple masking; primary purpose prevention. Start 2019-02-25 (actual); primary completion 2019-11-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effect of Oral Supplementation With Curcumin on Insulin Sensitivity in Subjects With Prediabetes
Condition
PreDiabetes
Intervention (Drug)
Curcumin
Intervention (Drug)
Starch
Lead sponsor
Hospital General de México Dr. Eduardo Liceaga (class: other government)

Record details

Record id
cardio:ct-nct03917784
Content hash
630968e003d0aa9b8665286363e0e629dc9a9c4987f538f880ab9e1b0c60b362